Loading...
Loading...
Among the 6 tracked institutional investors we monitor, ABUS (ARBUTUS BIOPHARMA CORP) is held with a combined value of $138.43M across 30,124,705 shares. The largest holder is BlackRock, Inc. with a position worth $58.35M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$138.43M
Total Shares Held
30,124,705
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $58.35M | 0.00% | -0.7% |
| 2 | VANGUARD GROUP INC | $44.46M | 0.00% | New |
| 3 | STATE STREET CORP | $28.54M | 0.00% | +7.4% |
| 4 | CITADEL ADVISORS LLC | $3.53M | 0.00% | +425.8% |
| 5 | MILLENNIUM MANAGEMENT LLC | $2.89M | 0.00% | New |
| 6 | FMR LLC | $653.07K | 0.00% | +6.3% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of ABUS with a position worth $58.35M, representing 0.00% of their portfolio. In total, 6 institutional investors hold ABUS with a combined value of $138.43M.
In the most recent quarter, 2 funds opened a new position in ABUS. Additionally, 3 increased their holdings and 1 reduced their positions.
Institutional investors hold $138.43M worth of ABUS stock across 6 positions. The largest institutional holder is BlackRock, Inc. with $58.35M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ABUS, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ABUS positions.